Generation Bio Co.
DelistedCIK 1733294fmd_1RPCF58ZZWFTKQGVQ1YJQAE9B0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2025, 26 periods
Latest annual · FY2024
Millions- Total revenues
- 20
- Operating income
- (142)
- Net income
- (132)
- Free cash flow
- (91)
Latest quarter · Q3 FY2025
Millions- Total revenues
- 2
- Operating income
- (7)
- Net income
- (6)
- Free cash flow
- (53)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
Generation Bio Co. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $19.9 million | $5.9 million | +236.9% | 10-K 2025-03-13 · proof |
| Operating income | -$142.4 million | -$138.6 million | 10-K 2025-03-13 · proof | |
| Net income | -$131.7 million | -$126.6 million | 10-K 2025-03-13 · proof | |
| Cash from operating activities | -$88.6 million | -$52.7 million | 10-K 2025-03-13 · proof | |
| Free cash flow | -$91 million | -$60.1 million | 10-K 2025-03-13 · proof | |
| Total assets | $231.2 million | $374.8 million | -38.3% | 10-K 2025-03-13 · proof |
| Total liabilities | $145 million | $171.6 million | -15.5% | 10-K 2025-03-13 · proof |
| Cash and cash equivalents | $76.3 million | $66.4 million | +14.8% | 10-K 2025-03-13 · proof |
- What was Generation Bio Co.'s revenue in fiscal 2024?
- Generation Bio Co. reported revenue of $19.9 million for fiscal 2024 (the year ended Dec 31, 2024), against $5.9 million the year before (+236.9%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Generation Bio Co.'s operating income in fiscal 2024?
- Generation Bio Co. reported operating income of -$142.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$138.6 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Generation Bio Co.'s net income in fiscal 2024?
- Generation Bio Co. reported net income of -$131.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$126.6 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Generation Bio Co.'s cash from operating activities in fiscal 2024?
- Generation Bio Co. reported cash from operating activities of -$88.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$52.7 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Generation Bio Co.'s free cash flow in fiscal 2024?
- Generation Bio Co. reported free cash flow of -$91 million for fiscal 2024 (the year ended Dec 31, 2024), against -$60.1 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Generation Bio Co.'s total assets?
- As of Dec 31, 2024, Generation Bio Co. reported total assets of $231.2 million, against $374.8 million a year earlier (-38.3%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Generation Bio Co.'s total liabilities?
- As of Dec 31, 2024, Generation Bio Co. reported total liabilities of $145 million, against $171.6 million a year earlier (-15.5%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Generation Bio Co.'s cash and cash equivalents?
- As of Dec 31, 2024, Generation Bio Co. reported cash and cash equivalents of $76.3 million, against $66.4 million a year earlier (+14.8%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1733294&period_type=annual&limit=5"Information only, not investment advice.